CS logo
small CS logo
Dominion Medical Associates, Inc.

Richmond, Virginia, United States
Family practice physician in Richmond, Virginia
304 E Leigh St, Richmond, VA 23219

About Dominion Medical Associates, Inc.


"Our mission is to provide our patients with exceptional care while transforming the health of the communities we serve."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
3
Boehringer Ingelheim
2
Eli Lilly and Company
2
Helixmith Co., Ltd.
2
AOBiome LLC
1
KBP Biosciences
1
LG Chem
1
Novartis Pharmaceuticals
1
Sunovion
1
Total Rows: 9

Clinical Trials at Dominion Medical Associates, Inc.


During the past decade, Dominion Medical Associates, Inc. conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11332244111111110000Started TrialsCompleted Trails201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
2009-06-01
2012-06-01
Completed
841
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
2014-07-25
2017-05-18
Completed
166
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
2018-06-26
2019-04-05
Completed
196
A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia
2019-12-02
2021-05-17
Completed
156
A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa
2019-09-16
2020-11-17
Completed
144
A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis
2019-10-16
2020-11-19
Completed
86
Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy
2020-10-09
2023-06-30
Active, not recruiting
160

Rows per page:

1–14 of 14

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Dominion Medical Associates, Inc." #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Helixmith Co., Ltd." with 2 trials sponsored and "AOBiome LLC" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Dominion Medical Associates, Inc." #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "bioRASI, LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsJanssen Research &Development, LLC: 3Janssen Research &Development, LLC: 3Boehringer Ingelheim: 2Boehringer Ingelheim: 2Eli Lilly and Company: 2Eli Lilly and Company: 2Helixmith Co., Ltd.: 2Helixmith Co., Ltd.: 2AOBiome LLC: 1AOBiome LLC: 1KBP Biosciences: 1KBP Biosciences: 1LG Chem: 1LG Chem: 1Novartis Pharmaceuticals: 1Novartis Pharmaceuticals: 1Sunovion: 1Sunovion: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 2Eli Lilly and Company: 2bioRASI, LLC: 1bioRASI, LLC: 1

Clinical Trials Conditions at Dominion Medical Associates, Inc.


According to Clinical.Site data, the most researched conditions in "Dominion Medical Associates, Inc." are "Atopic Dermatitis" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Acne Inversa" (1 trials), "Alzheimer Disease" (1 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Dominion Medical Associates, Inc." in a lesser frequency.

Clinical Trials Intervention Types at Dominion Medical Associates, Inc.


Most popular intervention types in "Dominion Medical Associates, Inc." are "Drug" (11 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Engensis" (2 trials), "placebo" (2 trials), "Arformoterol" (1 trials) and "B244" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Dominion Medical Associates, Inc.


The vast majority of trials in "Dominion Medical Associates, Inc." are 14 trials for "All" genders.

Clinical Trials Status at Dominion Medical Associates, Inc.


Currently, there are NaN active trials in "Dominion Medical Associates, Inc.". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Dominion Medical Associates, Inc., undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Dominion Medical Associates, Inc., 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 8Phase 3: 8Phase 2: 5Phase 2: 5Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 8Completed: 8Recruiting: 5Recruiting: 5Active, not recruiting: 1Active, not recruiting: 1